Topic: Pharmacy

One host recounts a disastrous experience with testosterone therapy from a compounding pharmacy, where his levels actually dropped after months of treatment. A humorous revelation occurs when it is discovered he was instructed to rub the cream on his testes, which the other host claims is completely incorrect and likely a "prank" by the pharmacy. They call for a real doctor to clarify the proper application of hormone treatments.

New FDA regulations and state-level guidelines in Virginia are making it more difficult for residents to obtain COVID-19 vaccines at local pharmacies. Some locations now require a doctor's prescription for the shot, creating hurdles for those under 65 who previously had easy walk-in access.

New recommendations for COVID-19 boosters limit eligibility to high-risk individuals, though the criteria include common factors like obesity and "physical inactivity." A news clip from Seattle features a senior citizen expressing fear of exposure from the unvaccinated, demonstrating the persistence of pandemic-era social divisions. The hosts mock the classification of sitting for long periods as a medical condition qualifying one for a booster.

President Trump signed an executive order aimed at slashing prescription drug costs by implementing "most favored nation" pricing. The order targets the "scam" of pharmacy benefit managers and insurance middlemen who inflate prices in the U.S. compared to international markets. Trump shared an anecdote about a billionaire friend paying $1,300 for a "fat shot" in New York that cost only $88 in London.

TikTok informed its sellers that the "de minimis" exemption for packages under $800 from China will be removed in May 2025, potentially crippling the platform's e-commerce model. Meanwhile, Amazon's CEO denied reports of a bid for TikTok, focusing instead on the company's expansion into home drug delivery.

Mainstream media outlets are running segments warning against the use of "black market" or compounded GLP-1 drugs like Ozempic. A segment on WGN featured a "nurse injector" discussing the dangers of incorrect dosages, citing a UK Big Brother contestant who became ill after taking five times the recommended amount. The pharmaceutical industry is reportedly attempting to shut down compounding pharmacies now that the official supply chain has stabilized.

Adam Curry describes falling ill with a flu-like bug while traveling in Florence, Italy. He claims to have successfully purchased and used Ivermectin from a local pharmacy to treat a sore throat and sinus issues. He jokes about infecting the planet with "bird flu" upon his return to the United States.

The Insurance Watchdog Coalition characterizes UnitedHealth as a vertical monopoly that controls every stage of patient care through its subsidiary, Optum. By employing 90,000 physicians and operating as a dominant pharmacy benefit manager, the company is accused of negotiating drug prices with itself to maximize profits. This structure allows the conglomerate to manage insurance claims while simultaneously owning the clinics and pharmacies providing the services.

CVS Health replaced its CEO as the company prepares to close 900 locations, following similar bankruptcy and closure trends at Walgreens and Rite Aid. The hosts discuss how insurance companies and "drugstore deserts" are driving consumers toward Amazon Pharmacy and mail-order prescriptions.

The CEO of Novo Nordisk faced questioning from U.S. Senators regarding why Ozempic costs nearly $1,000 in the U.S. compared to significantly lower prices in Europe and Canada. The drugmaker blamed Pharmacy Benefit Managers (PBMs) for inflating costs through complex rebate systems. Fitness expert Jillian Michaels also testified at a related hearing, criticizing the long-term health implications and marketing of weight-loss drugs.

A segment dedicated to acknowledging high-tier donors includes a discussion on the recurring appearance of the number 33 in media and the pandemic. A producer from California warns about state efforts to shut down compounding pharmacies, which provide essential treatments like Glutathione for firefighters. The segment concludes with the knighting of "Sir Cotton Gin."

Adam Curry deconstructs an NPR report on the "Ozempic town" of Bowling Green, Kentucky. He accuses NPR of carrying water for Big Pharma by casting doubt on the safety of cheaper, compounded versions of GLP-1 drugs. Curry argues that the media is attempting to protect brand-name profits by scaring low-income users away from off-brand alternatives.

Executives from the three largest Pharmacy Benefit Managers (PBMs)—CVS Caremark, Cigna Express Scripts, and UnitedHealth Optum—faced a bipartisan grilling in Congress. They are accused of inflating drug costs and squeezing independent pharmacies. Representative Ro Khanna cited a case of a child denied arthritis medication for six months due to PBM bureaucracy, while executives claimed they saved clients $64 billion.

Pharmaceutical giant Eli Lilly has partnered with Amazon Pharmacy to provide home delivery of its weight-loss drug Zepbound. The "LillyDirect" program aims to simplify access to the medication, which the hosts view as a sign of the increasingly commercialized and automated medical system.

The high cost of Ozempic in the U.S. is attributed to Pharmacy Benefit Managers (PBMs) who manipulate drug coverage and pricing. While the drug is patented until 2026, some patients are using compounded versions mixed with Vitamin B12 to save money, though the U.S. price remains significantly higher than in other countries.

A discussion of semaglutide and GLP-1 drugs focuses on the 1500% increase in reported overdoses. The narrative highlights how mainstream media outlets like CNN and ABC use the term "knockoffs" to describe compounded or generic versions of the drugs. The pharmaceutical industry's patent on the dosage dial is identified as a key factor in their marketing strategy against compounding pharmacies.

CNN's Sanjay Gupta reports a 1,500% increase in accidental overdoses of injected weight loss drugs. The report specifically targets compounding pharmacies that create alternative versions of Ozempic during shortages, warning that these versions are not tested for safety or efficacy.

Reports of gastroparesis, or stomach paralysis, have emerged among users of weight loss drugs like Ozempic and Wegovy. Dr. Darien Sutton explained that while these medications work by slowing gastric emptying, some patients experience severe complications requiring hospitalization. Despite these reports, medical contributors maintain that larger studies have not yet proven a definitive cause-and-effect relationship beyond the general population.

A pharmaceutical industry insider provides a breakdown of the differences between Ozempic and Wegovy, noting they are the same molecule (Semaglutide) but dosed differently for diabetes versus obesity. The source explains insurance hurdles, the "Ozempic face" phenomenon, and warns that compounding pharmacies are not sourcing their Semaglutide from the patent holder, Novo Nordisk.

The FDA issued a warning against using compounded versions of diabetes and weight loss drugs like Ozempic and Wegovy due to a nationwide shortage. The hosts argue this is a recurring attack on compounding pharmacies to protect the interests of major pharmaceutical advertisers who sell the brand-name versions at higher prices.